S. Yurimoto

Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase‐polymerase chain reaction

S. Yasuda, H. Makuuchi, S. Sadahiro, 2001, Cancer.

Detection of Carcinoembryonic Antigen Messenger RNA–Expressing Cells in Portal and Peripheral Blood During Surgery Does Not Influence Relapse in Colorectal Cancer

S. Yasuda, H. Makuuchi, S. Sadahiro, 2005, Annals of Surgical Oncology.

Quantitatively immunological characterization of mogamulizumab skin disorders in ATL patients

S. Iida, T. Ishii, A. Utsunomiya, 2019, Journal of Cutaneous Immunology and Allergy.

Safety and effectiveness of mogamulizumab in relapsed or refractory adult T‐cell leukemia‐lymphoma

Takeshi Takahashi, K. Tobinai, K. Ishitsuka, 2019, European journal of haematology.

Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia–lymphoma in Japan: interim results of postmarketing all-case surveillance

Takeshi Takahashi, K. Tobinai, K. Ishitsuka, 2017, International Journal of Hematology.

Enhancement of the anti-tumor activity of S-1 by low-dose cisplatin in mice bearing the sarcoma-180 model

T. Kamano, K. Sakamoto, A. Miyakawa, 2005, Anti-cancer drugs.

Detection of Carcinoembryonic Antigen Messenger RNA-Expressing Cells in Peripheral Blood 7 Days After Curative Surgery is a Novel Prognostic Factor in Colorectal Cancer

S. Yasuda, H. Makuuchi, S. Sadahiro, 2007, Annals of Surgical Oncology.